Biotricity, Inc.
BTCY
$0.43
-$0.0301-6.54%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 21.73% | 12.99% | 5.99% | 15.89% | 20.89% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 21.73% | 12.99% | 5.99% | 15.89% | 20.89% |
| Cost of Revenue | 6.22% | -9.45% | -24.05% | -24.98% | -23.86% |
| Gross Profit | 27.49% | 23.00% | 23.30% | 48.06% | 54.64% |
| SG&A Expenses | -20.53% | -35.51% | -15.74% | 7.55% | -31.33% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -10.97% | -29.59% | -19.09% | 0.43% | -32.44% |
| Operating Income | 86.82% | 85.92% | 51.79% | 11.85% | 66.61% |
| Income Before Tax | 56.23% | 57.68% | -8.25% | 10.48% | 37.83% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 56.23% | 57.68% | -8.25% | 10.48% | 37.83% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 56.23% | 57.68% | -8.25% | 10.48% | 37.83% |
| EBIT | 86.82% | 85.92% | 51.79% | 11.85% | 66.61% |
| EBITDA | 86.92% | 85.98% | 51.82% | 11.86% | 66.63% |
| EPS Basic | 83.96% | 83.34% | -19.17% | 16.20% | 37.91% |
| Normalized Basic EPS | 84.00% | 83.52% | 40.09% | -10.15% | 39.16% |
| EPS Diluted | 83.96% | 83.34% | -19.17% | 16.20% | 37.91% |
| Normalized Diluted EPS | 84.00% | 83.52% | 40.09% | -10.15% | 39.16% |
| Average Basic Shares Outstanding | 169.87% | 155.73% | 61.89% | 8.10% | 3.32% |
| Average Diluted Shares Outstanding | 169.87% | 155.73% | 61.89% | 8.10% | 3.32% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -1.21% | -1.42% | -0.83% | 1.00% | 0.96% |